TB screening with confidence
Welcome to the webinar hub for QuantiFERON-TB Gold Plus (QFT-Plus) and TB testing.
The WHO now recommends systematic testing and treatment of latent TB infection – and universally supports modern blood tests for patients at risk (1). It’s time to move on from the skin test and join the TB testing revolution with QFT-Plus.
To learn more about the benefits of QFT-Plus testing and hear about the latest testing guidelines from the CDC, IDSA, USCIS and more, watch our most recent webinars.
QFT-Plus webinar hub
QFT-Plus resources
References:
1. WHO. (2018) Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management. WHO/CDS/TB/2018.4.
QFT-Plus is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations.
For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user operator manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).